Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy https://www.medrxiv.org/content/10.1101/2023.08.04.23293666
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.